AI-Assisted Camera-Based Progressive Muscle Relaxation for Office Workers (AI-PMR)
17 maggio 2026 aggiornato da: dogukan kurc, Istanbul Medipol University Hospital
Effectiveness of an AI-Assisted Camera-Based Progressive Muscle Relaxation Application in Office Workers: A Randomized Controlled Trial
This randomized controlled trial evaluates the effectiveness of an AI-assisted, camera-based progressive muscle relaxation application in office workers aged 20 to 40 years.
Participants are randomly allocated to an intervention group or a control group.
The intervention group completes a 4-week progressive muscle relaxation program using the PhysioTR Academic application, which provides camera-based real-time movement analysis and exercise guidance.
The control group continues their usual daily routine and completes baseline and post-intervention assessments only.
Outcomes include pain/tension intensity, musculoskeletal symptoms, perceived stress, neck disability, work productivity, functionality, and AI-based adherence metrics.
Panoramica dello studio
Stato
Completato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
This study is a single-center, randomized, controlled, open-label trial conducted in office workers aged 20 to 40 years. Participants are automatically randomized into either an intervention group or a control group.
The intervention group uses the PhysioTR Academic application for a 4-week progressive muscle relaxation program. The program includes 3 sessions per week, 12 sessions in total. Each session includes four exercise components: face and jaw, neck and shoulders, hands and arms, and back and chest. Each exercise includes a contraction and relaxation phase. The application uses the participant's device camera for real-time movement analysis and provides written and/or audio guidance.
The control group continues their usual daily routine and does not receive an exercise intervention during the study period. The control group completes only baseline and post-intervention assessments.
Assessments are performed at baseline and Week 4. Outcome measures include the Visual Analog Scale, Nordic Musculoskeletal Questionnaire, Perceived Stress Scale, Neck Disability Index, Work Productivity Scale, numeric functionality score, and AI-based adherence and landmark coverage metrics in the intervention group.
Tipo di studio
Interventistico
Iscrizione (Effettivo)
60
Fase
- Non applicabile
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Luoghi di studio
-
-
Beykoz
-
Istanbul, Beykoz, Turchia (Türkiye), 34810
- Istanbul Medipol University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation
-
-
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
- Adulto
Accetta volontari sani
Sì
Descrizione
Inclusion Criteria:
- Aged between 20 and 40 years
- Actively working in a desk-based or office-based job
- Having access to a camera-enabled device such as a smartphone or computer
- Voluntary participation with informed consent
- Able to read and write Turkish
- Having a valid e-mail address
Exclusion Criteria:
- Previous surgery involving the neck or spine
- Cervical vertebral fracture or instability
- History of neurological disease such as multiple sclerosis or Parkinson's disease
- Vestibular system disorder
- Systemic inflammatory disease such as rheumatoid arthritis or ankylosing spondylitis
- History of malignancy
- Pregnancy
- Having received physiotherapy for the neck or back region within the last 6 months
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Terapia di supporto
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: AI-Assisted Camera-Based Progressive Muscle Relaxation Group
Participants in this group complete a 4-week progressive muscle relaxation program using the PhysioTR Academic application.
The program includes 3 sessions per week, 12 sessions in total.
Each session includes four components: face and jaw, neck and shoulders, hands and arms, and back and chest.
The application uses the participant's device camera for real-time movement analysis and records session-level Visual Analog Scale scores and AI-based adherence metrics.
|
A camera-based progressive muscle relaxation program delivered through the PhysioTR Academic web application.
The intervention includes 4 weeks of training, 3 sessions per week, for a total of 12 sessions.
The application provides written and/or audio instructions and uses camera-based real-time movement analysis to support exercise performance and adherence monitoring.
|
|
Nessun intervento: Control Group
Participants in the control group continue their usual daily routine and do not receive an exercise intervention during the study period.
They complete baseline and Week 4 assessments only.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Pain/Tension Intensity Assessed by Visual Analog Scale
Lasso di tempo: Baseline and Week 4
|
Pain/tension intensity is assessed using a 0-10 Visual Analog Scale.
Higher scores indicate greater pain/tension intensity.
Change is calculated from baseline to Week 4.
|
Baseline and Week 4
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Musculoskeletal Symptoms Assessed by the Nordic Musculoskeletal Questionnaire
Lasso di tempo: Baseline and Week 4
|
Musculoskeletal symptoms are assessed using the Nordic Musculoskeletal Questionnaire across body regions.
The outcome is summarized as the presence of symptoms by region and/or the number of symptomatic body regions.
Higher values indicate more widespread musculoskeletal symptoms.
|
Baseline and Week 4
|
|
Change in Perceived Stress Scale Score
Lasso di tempo: Baseline and Week 4
|
Perceived stress is assessed using the Turkish version of the Perceived Stress Scale.
Higher scores indicate greater perceived stress.
|
Baseline and Week 4
|
|
Change in Neck Disability Index Score
Lasso di tempo: Baseline and Week 4
|
Neck-related disability is assessed using the Neck Disability Index.
Higher scores indicate greater neck-related disability.
|
Baseline and Week 4
|
|
Change in Work Productivity Scale Score
Lasso di tempo: Baseline and Week 4
|
Work productivity is assessed using a 5-item Likert-type Work Productivity Scale.
Total scores range from 5 to 25, with higher scores indicating higher work productivity.
|
Baseline and Week 4
|
|
Change in Numeric Functionality Score
Lasso di tempo: Baseline and Week 4
|
General functionality is assessed using a numeric rating scale from 0 to 10, where 0 indicates very poor functionality and 10 indicates excellent functionality.
Higher scores indicate better functionality.
|
Baseline and Week 4
|
|
AI-Based Exercise Adherence Score
Lasso di tempo: During each of the 12 sessions over the 4-week intervention period
|
In the intervention group, the application automatically calculates an AI-based adherence score as the percentage of predefined exercise criteria met during each session.
Scores range from 0 to 100%, with higher scores indicating better adherence to the required exercise form.
|
During each of the 12 sessions over the 4-week intervention period
|
|
AI-Based Landmark Coverage Ratio
Lasso di tempo: During each of the 12 sessions over the 4-week intervention period
|
In the intervention group, the application calculates a landmark coverage ratio as the percentage of required body landmarks detected by the camera during each exercise.
Scores range from 0 to 100%, with higher scores indicating better camera-based landmark detection.
|
During each of the 12 sessions over the 4-week intervention period
|
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Immediate Change in Session-Level Pain/Tension Intensity
Lasso di tempo: Immediately before and after each session during the 4-week intervention period
|
In the intervention group, pain/tension intensity is recorded immediately before and after each progressive muscle relaxation session using a 0-10 Visual Analog Scale.
The immediate session-level change is calculated as post-session score minus pre-session score.
|
Immediately before and after each session during the 4-week intervention period
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio (Effettivo)
8 aprile 2026
Completamento primario (Effettivo)
13 maggio 2026
Completamento dello studio (Effettivo)
13 maggio 2026
Date di iscrizione allo studio
Primo inviato
30 aprile 2026
Primo inviato che soddisfa i criteri di controllo qualità
30 aprile 2026
Primo Inserito (Effettivo)
7 maggio 2026
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
20 maggio 2026
Ultimo aggiornamento inviato che soddisfa i criteri QC
17 maggio 2026
Ultimo verificato
1 maggio 2026
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- PHYSIOTR-PMR-2026-001
- Ethics Approval No. 515 (Altro identificatore: Istanbul Medipol University)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
NO
Descrizione del piano IPD
Individual participant data will not be publicly shared due to ethical approval conditions and personal data protection requirements.
De-identified aggregate data may be made available from the corresponding investigator upon reasonable request, subject to institutional and ethics approval.
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
No
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
No
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .